Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance

Jessica Godin-Ethier, Sandy Pelletier, Laïla Aïcha Hanafi, Philippe O. Gannon, Marie Andrée Forget, Jean Pierre Routy, Mohamed Rachid Boulassel, Urszula Krzemien, Simon Tanguay, Jean Baptiste Lattouf, Nathalie Arbour, Réjean Lapointe

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Previous cancer vaccination approaches have shown some efficiency in generating measurable immune responses, but they have rarely led to tumor regression. It is therefore possible that tumors emerge with the capacity to down-regulate immune counterparts, through the local production of immunosuppressive molecules, such as IDO. Although it is known that IDO exerts suppressive effects on T cell functions, the mechanisms of IDO regulation in tumor cells remain to be characterized. Here, we demonstrate that activated T cells can induce functional IDO expression in breast and kidney tumor cell lines, and that this is partly attributable to IFN-γ. Moreover, we found that IL-13, a Th2 cytokine, has a negative modulatory effect on IDO expression. Furthermore, we report IDO expression in the majority of breast and kidney carcinoma samples, with infiltration of activated Th1-polarized T cells in human tumors. These findings demonstrate complex control of immune activity within tumors. Future immune therapeutic interventions should thus include strategies to counteract these negative mechanisms.

Original languageEnglish
Pages (from-to)7752-7760
Number of pages9
JournalJournal of Immunology
Volume183
Issue number12
DOIs
Publication statusPublished - Dec 15 2009

Fingerprint

Th1-Th2 Balance
T-Lymphocytes
Neoplasms
Breast Neoplasms
Kidney
Interleukin-13
Immunosuppressive Agents
Antigen-Antibody Complex
Tumor Cell Line
Vaccination
Down-Regulation
Cytokines

ASJC Scopus subject areas

  • Immunology

Cite this

Godin-Ethier, J., Pelletier, S., Hanafi, L. A., Gannon, P. O., Forget, M. A., Routy, J. P., ... Lapointe, R. (2009). Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. Journal of Immunology, 183(12), 7752-7760. https://doi.org/10.4049/jimmunol.0901004

Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. / Godin-Ethier, Jessica; Pelletier, Sandy; Hanafi, Laïla Aïcha; Gannon, Philippe O.; Forget, Marie Andrée; Routy, Jean Pierre; Boulassel, Mohamed Rachid; Krzemien, Urszula; Tanguay, Simon; Lattouf, Jean Baptiste; Arbour, Nathalie; Lapointe, Réjean.

In: Journal of Immunology, Vol. 183, No. 12, 15.12.2009, p. 7752-7760.

Research output: Contribution to journalArticle

Godin-Ethier, J, Pelletier, S, Hanafi, LA, Gannon, PO, Forget, MA, Routy, JP, Boulassel, MR, Krzemien, U, Tanguay, S, Lattouf, JB, Arbour, N & Lapointe, R 2009, 'Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance', Journal of Immunology, vol. 183, no. 12, pp. 7752-7760. https://doi.org/10.4049/jimmunol.0901004
Godin-Ethier J, Pelletier S, Hanafi LA, Gannon PO, Forget MA, Routy JP et al. Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. Journal of Immunology. 2009 Dec 15;183(12):7752-7760. https://doi.org/10.4049/jimmunol.0901004
Godin-Ethier, Jessica ; Pelletier, Sandy ; Hanafi, Laïla Aïcha ; Gannon, Philippe O. ; Forget, Marie Andrée ; Routy, Jean Pierre ; Boulassel, Mohamed Rachid ; Krzemien, Urszula ; Tanguay, Simon ; Lattouf, Jean Baptiste ; Arbour, Nathalie ; Lapointe, Réjean. / Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. In: Journal of Immunology. 2009 ; Vol. 183, No. 12. pp. 7752-7760.
@article{e0e4b1692de947928d185100111e8521,
title = "Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance",
abstract = "Previous cancer vaccination approaches have shown some efficiency in generating measurable immune responses, but they have rarely led to tumor regression. It is therefore possible that tumors emerge with the capacity to down-regulate immune counterparts, through the local production of immunosuppressive molecules, such as IDO. Although it is known that IDO exerts suppressive effects on T cell functions, the mechanisms of IDO regulation in tumor cells remain to be characterized. Here, we demonstrate that activated T cells can induce functional IDO expression in breast and kidney tumor cell lines, and that this is partly attributable to IFN-γ. Moreover, we found that IL-13, a Th2 cytokine, has a negative modulatory effect on IDO expression. Furthermore, we report IDO expression in the majority of breast and kidney carcinoma samples, with infiltration of activated Th1-polarized T cells in human tumors. These findings demonstrate complex control of immune activity within tumors. Future immune therapeutic interventions should thus include strategies to counteract these negative mechanisms.",
author = "Jessica Godin-Ethier and Sandy Pelletier and Hanafi, {La{\"i}la A{\"i}cha} and Gannon, {Philippe O.} and Forget, {Marie Andr{\'e}e} and Routy, {Jean Pierre} and Boulassel, {Mohamed Rachid} and Urszula Krzemien and Simon Tanguay and Lattouf, {Jean Baptiste} and Nathalie Arbour and R{\'e}jean Lapointe",
year = "2009",
month = "12",
day = "15",
doi = "10.4049/jimmunol.0901004",
language = "English",
volume = "183",
pages = "7752--7760",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance

AU - Godin-Ethier, Jessica

AU - Pelletier, Sandy

AU - Hanafi, Laïla Aïcha

AU - Gannon, Philippe O.

AU - Forget, Marie Andrée

AU - Routy, Jean Pierre

AU - Boulassel, Mohamed Rachid

AU - Krzemien, Urszula

AU - Tanguay, Simon

AU - Lattouf, Jean Baptiste

AU - Arbour, Nathalie

AU - Lapointe, Réjean

PY - 2009/12/15

Y1 - 2009/12/15

N2 - Previous cancer vaccination approaches have shown some efficiency in generating measurable immune responses, but they have rarely led to tumor regression. It is therefore possible that tumors emerge with the capacity to down-regulate immune counterparts, through the local production of immunosuppressive molecules, such as IDO. Although it is known that IDO exerts suppressive effects on T cell functions, the mechanisms of IDO regulation in tumor cells remain to be characterized. Here, we demonstrate that activated T cells can induce functional IDO expression in breast and kidney tumor cell lines, and that this is partly attributable to IFN-γ. Moreover, we found that IL-13, a Th2 cytokine, has a negative modulatory effect on IDO expression. Furthermore, we report IDO expression in the majority of breast and kidney carcinoma samples, with infiltration of activated Th1-polarized T cells in human tumors. These findings demonstrate complex control of immune activity within tumors. Future immune therapeutic interventions should thus include strategies to counteract these negative mechanisms.

AB - Previous cancer vaccination approaches have shown some efficiency in generating measurable immune responses, but they have rarely led to tumor regression. It is therefore possible that tumors emerge with the capacity to down-regulate immune counterparts, through the local production of immunosuppressive molecules, such as IDO. Although it is known that IDO exerts suppressive effects on T cell functions, the mechanisms of IDO regulation in tumor cells remain to be characterized. Here, we demonstrate that activated T cells can induce functional IDO expression in breast and kidney tumor cell lines, and that this is partly attributable to IFN-γ. Moreover, we found that IL-13, a Th2 cytokine, has a negative modulatory effect on IDO expression. Furthermore, we report IDO expression in the majority of breast and kidney carcinoma samples, with infiltration of activated Th1-polarized T cells in human tumors. These findings demonstrate complex control of immune activity within tumors. Future immune therapeutic interventions should thus include strategies to counteract these negative mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=76249093444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76249093444&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.0901004

DO - 10.4049/jimmunol.0901004

M3 - Article

VL - 183

SP - 7752

EP - 7760

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -